Canacan, Tumagantang D.

HRN: 14-90-48  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/12/2025
CEFTRIAXONE 1G (VIAL)
08/12/2025
09/02/2025
IV
2g
Q24h
Sacral Ulcer
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: